-
GLMD Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
-
Insider
- Institutional
- Shorts
Galmed Pharmaceuticals (GLMD)
Company Profile
Quarter (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
13F holders | Current |
---|---|
Total holders | 11 |
Opened positions | 3 |
Closed positions | 13 |
Increased positions | 0 |
Reduced positions | 6 |
13F shares | Current |
---|---|
Total value | 417.02 mm |
Total shares | 5.30 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Baharaff Allen | 3.42 mm | $0.00 |
Biotechnology Value Fund L P | 1.74 mm | $0.00 |
BVF | 89.85 k | $261.47 mm |
Susquehanna International | 25.60 k | $74.49 mm |
Millennium Management | 14.91 k | $43.38 mm |
MS Morgan Stanley | 12.50 k | $37.37 mm |
TSFG | 200.00 | $1.00 k |
Tower Research Capital | 51.00 | $152.00 k |
Bourgeon Capital Management | 34.00 | $102.00 k |
Allworth Financial | 17.00 | $51.00 k |